The Human Epidermal Growth Factor Receptor 2 (HER2)-amplified subtype is characterized by the amplification and overexpression of the v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) gene and represents ~20% of breast tumours. The gene discussed is ERBB2; the disease is breast neoplasm.